Nice — I pulled recent market reports and company filings and assembled a compact, sourced reference pack for the Sterilization Equipment market. Below you’ll find (A) market-size snapshots, (B) a vendor list with public company revenue values where available, and (C) the requested analysis sections (recent development, drivers, restraints, regional split, trends, use cases, challenges, opportunities, and key expansion factors). I cite the most important sources for the load-bearing facts.

This versatile research report is presenting crucial details on market relevant information, harping on ample minute details encompassing a multi-dimensional market that collectively maneuver growth in the global Sterilization Equipment market.

This holistic report presented by the report is also determined to cater to all the market specific information and a take on business analysis and key growth steering best industry practices that optimize million-dollar opportunities amidst staggering competition in Sterilization Equipment market.

Read complete report at: https://www.thebrainyinsights.com/report/sterilization-equipment-market-13396

Quick market snapshot

  • Grand View Research estimates the global sterilization equipment market at ~USD 7.9 billion in 2024, projecting growth to ~USD 15.0B by 2030 (CAGR ~11.3% 2025–2030).

  • Other reputable reports use slightly different bases — Fortune Business Insights (example model) projects ~USD 10.98B in 2024 → USD 23.56B by 2032 (CAGR ~10.2%). GMI Insights gives similar multi-billion 2024 baselines. These differences reflect varying inclusion rules (equipment vs services vs consumables).

Key vendors — company references & public values (selected)

Note: most companies report consolidated revenues (they rarely break out sterilization-only sales). I list the company + latest public FY figure and a short note on sterilization role.

  • STERIS plc — Revenue (Fiscal 2024): $5.5 billion. Global provider of sterilizers, washer-disinfectors and sterilization consumables for hospitals and life-sciences.

  • Getinge AB — Net sales (2024): 34.8 billion SEK (group). Getinge supplies steam and low-temperature sterilizers, washer-disinfectors and integrated CSSD solutions.

  • 3M — Sales (FY 2024): $24.6 billion (3M’s healthcare segment includes sterilization-related products such as sterilization wraps, indicators, infection-prevention products).

  • Fortive (Advanced Sterilization Products, ASP) — Revenue (Fortive FY 2024): ~$6.23 billion (group); Fortive’s ASP business (STERRAD™ hydrogen-peroxide plasma sterilizers) is a major low-temperature sterilizer brand.

  • Sotera Health (Sterigenics, Nelson Labs, Nordion) — Net revenues (2024): ~ $1.10 billion (group); Sterigenics operates contract sterilization (EO, gamma) services and related equipment for medical device sterilization.

  • Belimed (SteelcoBelimed JV / Metall Zug group affiliation) — specialist in sterilizers and washer-disinfectors for hospitals & life-science; now positioned in the SteelcoBelimed combination (private / JV reporting). (Company-level numbers available via Metall Zug / SteelcoBelimed disclosures).

(Other notable players mentioned across market reports: Cardinal Health (sterilization products & supplies), Steris/STERIS competitors in OEM & service markets, smaller regional OEMs and contract sterilization service providers.)

Recent developments (2023–2025)

  • Market consolidation and service-provider growth: contract sterilization providers (gamma/EO) and equipment OEMs have continued transactions and growth as device manufacturers outsource sterilization capacity. Sotera/Sterigenics results and other M&A/portfolio adjustments reflect this. 

  • Demand is rising for low-temperature sterilization (H₂O₂ plasma, VHP) driven by reusable endoscope processing and heat-sensitive device sterilization; vendors have refreshed product lines and received new clearances. 

Drivers

  • Growth in surgical procedures, medical-device volumes and life-sciences manufacturing (R&D, biologics) increases demand for robust sterilization equipment.

  • Regulatory emphasis on infection prevention, stricter reprocessing requirements for complex devices (endoscopes) and hospital accreditation pressures.

Restraints

  • High capex for centralized sterilization suites and long hospital procurement cycles.

  • Safety/environmental concerns and litigation around certain sterilants (e.g., ethylene oxide / EtO emissions) affecting facility siting and operations for contract sterilizers.

Regional segmentation (high level)

  • North America: large installed base, strong contract-sterilization services market, and regulatory scrutiny on EtO use (impacting EO sterilization providers).

  • Europe: mature market with strong hospital CSSD modernization and life-sciences manufacturing demand (Getinge, STERIS strong).

  • Asia-Pacific: fastest growth in equipment demand (hospital expansion, rising procedure volumes, new med-tech manufacturing capacity).

Emerging trends

  • Shift toward low-temperature sterilization (hydrogen peroxide gas plasma / vaporized H₂O₂) for heat-sensitive devices.

  • Service + equipment bundles: OEMs offering installation, validation, and managed-services contracts (sterilizer uptime guarantees, qualification services).

  • Environmental & safety focus: alternatives to EtO, emissions controls and community engagement after EtO controversies.

Top use cases

  1. Hospital Central Sterile Supply Departments (CSSD) — steam sterilizers, washer-disinfectors.

  2. Low-temperature sterilization for heat-sensitive devices (STERRAD™, VHP systems).

  3. Contract sterilization (gamma, EtO) for medical-device OEMs and disposable products.

  4. Life-sciences & pharmaceutical sterilization for equipment, components and bioprocessing tools.

Major challenges

  • Regulatory & community pressure on EtO use (compliance costs, potential plant closures or retrofit CAPEX).

  • Long qualification cycles for devices/equipment and high validation burden for hospitals and OEMs.

  • Managing capital & service economics when hospitals delay refresh cycles during budget constraints.

Attractive opportunities

  • Hospital CSSD modernization (automation, traceability, instrument tracking + validated sterilization cycles).

  • Contract sterilization expansion where OEMs outsource capacity (esp. in regions with growing device manufacturing).

  • Aftermarket services & consumables (indicators, wraps, filters, validation kits) — recurring revenue for OEMs and suppliers.

Key factors of market expansion

  • Rising surgical volumes and medical-device production.

  • Regulatory tightening and infection-prevention mandates that elevate equipment replacement/upgrade cycles.

  • Technology adoption (low-temp sterilization, automation, process validation tools) and growth of contract sterilization services.

 

Would you like this turned into a downloadable deliverable now?

  • I can build a vendor table (CSV): company | HQ | FY-2024 revenue (public) | sterilization role (equipment / contract services / consumable) | primary source and attach it.

  • Or I can create a 1-page PPTX summarizing market size, top 8 suppliers and 3 strategic moves for an OEM or service provider.

Pick one and I’ll generate it right away.